Beard, 47, had previously sought a GLP-1 prescription, but her doctor "wouldn't even try" to get it approved, assuming her insurance company would reject coverage of the costly medication, she said
zinc supplementation, penicillamine, other chelators), consult with a knowledgeable physician before starting
6 MAR709 had finished its Phase 2a clinical trial in 2017, 51 and it is a balanced dual agonist for GLP-1R and GIPR
Importantly, patients should be aware of key safety concerns with Wegovy, including risks of pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, and potential worsening of diabetic retinopathy in people with type 2 diabetes